Scheme 29
If you can tolerate weekly dosing, the evidence strongly supports sticking with it
Combining retatrutide with anabolic substances or performance-enhancing drugs as sometimes discussed in online forums is not clinically sanctioned and may carry serious cardiovascular and endocrine risks
Moreover, some authors have suggested that hyperinsulinemia, hyperglycemia, and chronic inflammation typical of untreated DM would be risk factors for TC development and/or progression (Jee et al., 2005
Some users stack tirzepatide with other peptides like BPC-157 for gut health, ipamorelin for growth hormone support, or sermorelin for recovery
Thus, it's possible that better efficacy could be achieved with either semaglutide, 2.4 mg, or tirzepatide in PWS but it will be critical to also understand the safety and tolerance for individuals with PWS